The Hypothalamic-Neurohypophyseal System: From Genome to Physiology

Journal of Neuroendocrinology

Volumn 24, Issue 4, 2012, Pages 539-553

  Murphy, D ^a,b   Konopacka, A ^a   Hindmarch, C ^a   Paton, J F R ^c   Sweedler, J V ^d   Gillette, M U ^d   Ueta, Y ^e   Grinevich, V ^f   Lozic, M ^b   Japundzic Zigon, N ^b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

^d UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^e UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^f MAX PLANCK INSTITUTE FOR MEDICAL RESEARCH   (Germany)

Author keywords

Genome; Hypothalamic neurohypophyseal system; Neuropeptidome; Oxytocin; Proteome; Transcriptome; Transgenic rats; Vasopressin; Viral vectors

Indexed keywords

ADENOSINE DEAMINASE; CIS ACTING ELEMENT; HORMONE PRECURSOR; MESSENGER RNA; OXYTOCIN; PROTEIN C FOS; PROTEOME; SPACER DNA; VASOPRESSIN; VIRUS VECTOR;

ADENOVIRUS; BEHAVIOR CONTROL; BLOOD VOLUME; BRAIN ELECTROPHYSIOLOGY; CARDIOVASCULAR FUNCTION; CIRCADIAN RHYTHM; DEHYDRATION; ENDOCRINE FUNCTION; EXON SHUFFLING; FEEDING BEHAVIOR; FLUORESCENCE MICROSCOPY; GENE IDENTIFICATION; GENE SEQUENCE; GENOME; HOMEOSTASIS; HYPERTENSION; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMMUNOHISTOCHEMISTRY; MASS SPECTROMETRY; NEUROANATOMY; NONHUMAN; OBESITY; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN SYNTHESIS; RECEPTOR BINDING; REGULATORY MECHANISM; REVIEW; RNA EDITING; SOCIAL BEHAVIOR; TRANSCRIPTION REGULATION; TRANSCRIPTOMICS; TRANSGENE; VASCULAR RESISTANCE;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ARGININE VASOPRESSIN; BAROREFLEX; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENOME; HUMANS; HYPERTENSION; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; NEUROPEPTIDES; OXYTOCIN;

EID: 84858832918     PISSN: 09538194     EISSN: 13652826     Source Type: Journal    
DOI: 10.1111/j.1365-2826.2011.02241.x     Document Type: Review

References (107)

1. Crick FH. On protein synthesis. Symp Soc Exp Biol 1958; 12: 138-163.
2. Crick FH. Central dogma of molecular biology. Nature 1970; 227: 561-563.
3. Ingram VM. Gene mutations in human haemoglobin: the chemical difference between normal and sickle cell haemoglobin. Nature 1957; 180: 326-328.
4. Beadle GW, Tatum EL. Genetic control of biochemical reactions in Neurospora. Proc Natl Acad Sci USA 1941; 27: 499-506.
5. Pertea M, Salzberg SL. Between a chicken and a grape: estimating the number of human genes. Genome Biol 2010; 11: 206.
6. Vogel F. A preliminary estimate of the number of human genes. Nature 1964; 201: 847.
7. International Human Genome Sequencing Consortium. Initial sequencing and analysis of the human genome. Nature 2001; 409: 860-921.
8. Pan Q, Shai O, Lee LJ, Frey BJ, Blencowe BJ. Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nature Genet 2008; 40: 1413-1415.
9. Wang ET, Sandberg R, Luo S, Khrebtukova I, Zhang L, Mayr C, Kingsmore SF, Schroth GP, Burge CB. Alternative isoform regulation in human tissue transcriptomes. Nature 2008; 456: 470-476.
10. Ramani AK, Calarco JA, Pan Q, Mavandadi S, Wang Y, Nelson AC, Lee LJ, Morris Q, Blencowe BJ, Zhen M, Fraser AG. Genome-wide analysis of alternative splicing in Caenorhabditis elegans. Genome Res 2011; 21: 342-348.
11. Foo NC, Funkhouser JM, Carter DA, Murphy D. A testis-specific promoter in the rat vasopressin gene. J Biol Chem 1994; 269: 659-667.
12. Bass BL. RNA editing by adenosine deaminases that act on RNA. Ann Rev Biochem 2002; 71: 817-846.
13. Mattick JS, Mehler MF. RNA editing, DNA recoding and the evolution of human cognition. Trends Neurosci 2008; 31: 227-233.
14. Li M, Wang IX, Li Y, Bruzel A, Richards AL, Toung JM, Cheung VG. Widespread RNA and DNA sequence differences in the human transcriptome. Science 2011; 333: 53-58.
15. Burbach JP, Luckman SM, Murphy D, Gainer H. Gene regulation in the magnocellular hypothalamo-neurohypophysial system. Physiol Rev 2001; 81: 1197-1267.
16. Ohno S. So much 'junk' DNA in our genome in evolution of genetic systems. In: Smith HH, ed. Brookhaven Symposia in Biology 23. New York: Gordon and Breach, 1972: 366-370.
17. Davidson EH, Britten RJ. Organization, transcription and regulation of the animal genome. Quart Rev Biol 1973; 48: 565-613.
18. Odom DT, Dowell RD, Jacobsen ES, Gordon W, Danford TW, MacIsaac KD, Rolfe PA, Conboy CM, Gifford DK, Fraenkel E. Tissue-specific transcriptional regulation has diverged significantly between human and mouse. Nat Genet 2007; 39: 730-732.
19. Ang HL, Ungefroren H, De Bree F, Foo NC, Carter D, Burbach JP, Ivell R, Murphy D. Testicular oxytocin gene expression in seminiferous tubules of cattle and transgenic mice. Endocrinology 1991; 128: 2110-2117.
20. McGraw LA, Young LJ. The prairie vole: an emerging model organism for understanding the social brain. Trends Neurosci 2010; 33: 103-109.
21. Lim MM, Young LJ. Vasopressin-dependent neural circuits underlying pair bond formation in the monogamous prairie vole. Neuroscience 2004; 125: 35-45.
22. Liu Y, Curtis JT, Wang Z. Vasopressin in the lateral septum regulates pair bond formation in male prairie voles (Microtus ochrogaster). Behav Neurosci 2001; 115: 910-919.
23. Young LJ, Wang Z. The neurobiology of pair bonding. Nat Neurosci 2004; 7: 1048-1054.
24. Lim MM, Wang Z, Olazábal DE, Ren X, Terwilliger EF, Young LJ. Enhanced partner preference in a promiscuous species by manipulating the expression of a single gene. Nature 2004; 429: 754-757.
25. Hammock EAD, Young LJ. On switches and knobs, microsatellites and monogamy. Trends Genet 2007; 23: 209-212.
26. Young LJ, Nilsen R, Waymire KG, MacGregor GR, Insel TR. Increased affiliative response to vasopressin in mice expressing the vasopressin receptor from a monogamous vole. Nature 1999; 400: 766-768.
27. Ophir AG, Campbell P, Hanna K, Phelps SM. Field tests of cis-regulatory variation at the prairie vole avpr1a locus: association with V1aR abundance but not sexual or social fidelity. Horm Behav 2008; 54: 694-702.
28. FANTOM Consortium, RIKEN Genome Exploration Research Group and Genome Science Group (Genome Network Project Core Group). The transcriptional landscape of the mammalian genome. Science 2005; 309: 1559-1563.
29. Carnici P. RNA dust: where are the genes? DNA Res 2010; 17: 51-59.
30. RIKEN Genome Exploration Research Group, Genome Science Group (Genome Network Project Core Group), FANTOM Consortium. Antisense transcription in the mammalian transcriptome. Science 2005; 309: 1564-1566.
31. Rearick D, Prakash A, McSweeny A, Shepard SS, Fedorova L, Fedorov A. Critical association of ncRNA with introns. Nucleic Acids Res 2011; 39: 2357-2366.
32. Kaikkonen MU, Lam MT, Glass CK. Non-coding RNAs as regulators of gene expression and epigenetics. Cardiovasc Res 2011; 90: 430-440.
33. Wilusz JE, Sunwoo H, Spector DL. Long noncoding RNAs: functional surprises from the RNA world. Genes Dev 2009; 23: 1494-1504.
34. Lee HJ, Palkovits M, Young WS III. miR-7b, a microRNA up-regulated in the hypothalamus after chronic hyperosmolar stimulation, inhibits Fos translation. Proc Natl Acad Sci USA 2006; 103: 15669-15674.
35. Cunningham JT, Penny ML, Murphy D. Cardiovascular regulation of supraoptic neurons in the rat: synaptic inputs and cellular signals. Prog Biophys Mol Biol 2004; 84: 183-196.
36. Fujihara H, Ueta Y, Suzuki H, Katoh A, Ohbuchi T, Otsubo H, Dayanithi G, Murphy D. Robust up-regulation of nuclear red fluorescent-tagged fos marks neuronal activation in green fluorescent vasopressin neurons after osmotic stimulation in a double-transgenic rat. Endocrinology 2009; 150: 5633-5638.
37. Vandesande F, Dierickx K, De Mey J. The origin of the vasopressinergic and oxytocinergic fibres of the external region of the median eminence of the rat hypophysis. Cell Tissue Res 1977; 180: 443-452.
38. Sawchenko PE, Swanson LW. Immunohistochemical identification of neurons in the paraventricular nucleus of the hypothalamus that project to the medulla or to the spinal cord in the rat. J Comp Neurol 1982; 205: 260-272.
39. Yang Z, Coote JH. Influence of the hypothalamus paraventricular nucleus on cardiovascular neurones in the rostral ventrolateral medulla of the rat. J Physiol 1999; 513: 521-530.
40. Hardy SG. Hypothalamic projections to cardiovascular centers of the medulla. Brain Res 2001; 894: 233-240.
41. Coote JH. A role for the paraventricular nucleus of the hypothalamus in the autonomic control of heart and kidney. Exp Physiol 2005; 90: 169-173.
42. Sladek CD, Devine MA, Felten SY, Aravich PF, Blair ML. Abnormalities in hypothalamic and neurohypophysial vasopressin content are not a consequence of hypertension in the spontaneously hypertensive rat. Brain Res 1988; 445: 39-46.
43. Allen AM. Inhibition of the hypothalamic paraventricular nucleus in spontaneously hypertensive rats dramatically reduces sympathetic vasomotor tone. Hypertension 2002; 39: 275-280.
44. Martin DS, Haywood JR. Reduced GABA inhibition of sympathetic function in renal-wrapped hypertensive rats. Am J Physiol 1998; 275: R1523-R1529.
45. Hindmarch C, Yao S, Beighton G, Paton J, Murphy D. A comprehensive description of the transcriptome of the hypothalamo-neurohypophyseal system in euhydrated and dehydrated rats. Proc Natl Acad Sci USA 2006; 103: 1609-1614.
46. Qiu J, Hindmarch CC, Yao ST, Tasker JG, Murphy D. Transcriptomic analysis of the osmotic and reproductive remodeling of the female rat supraoptic nucleus. Endocrinology 2011; 152: 3483-3491.
47. Qiu J, Yao S, Hindmarch C, Antunes V, Paton J, Murphy D. Transcription factor expression in the hypothalamo-neurohypophyseal system of the dehydrated rat: upregulation of gonadotrophin inducible transcription factor 1 mRNA is mediated by cAMP-dependent protein kinase A. J Neurosci 2007; 27: 2196-2203.
48. Hazell GG, Hindmarch CC, Pope GR, Roper JA, Lightman SL, Murphy D, O'Carroll AM, Lolait SJ. G protein-coupled receptors in the hypothalamic paraventricular and supraoptic nuclei - serpentine gateways to neuroendocrine homeostasis. Front Neuroendocrinol 2011. In Press.
49. Yue C, Mutsuga N, Verbalis J, Gainer H. Microarray analysis of gene expression in the supraoptic nucleus of normoosmotic and hypoosmotic rats. Cell Mol Neurobiol 2006; 26: 959-978.
50. Hindmarch C, Yao S, Hesketh S, Jessop D, Harbuz M, Paton J, Murphy D. The transcriptome of the rat hypothalamic-neurohypophyseal system is highly strain-dependent. J Neuroendocrinol 2007; 19: 1009-1012.
51. Ye ZY, Li DP, Li L, Pan HL. Protein kinase CK2 increases glutamatergic input in the hypothalamus and sympathetic vasomotor tone in hypertension. J Neurosci 2011; 31: 8271-8279.
52. Wang Z, Gerstein M, Snyder M. RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet 2009; 10: 57-63.
53. Blencowe BJ, Ahmad S, Lee LJ. Current-generation high-throughput sequencing: deepening insights into mammalian transcriptomes. Genes Dev 2009; 23: 1379-1386.
54. Mutsuga N, Shahar T, Verbalis JG, Brownstein MJ, Xiang CC, Bonner RF, Gainer H. Selective gene expression in magnocellular neurons in rat supraoptic nucleus. J Neurosci 2004; 24: 7174-7185.
55. de Sousa Abreu R, Penalva LO, Marcotte EM, Vogel C. Global signatures of protein and mRNA expression levels. Mol Biosyst 2009; 5: 1512-1526.
56. Maier T, Guell M, Serrano L. Correlation of mRNA and protein in complex biological samples. FEBS Lett 2009; 583: 3966-3973.
57. Lu R, Markowetz F, Unwin RD, Leek JT, Airoldi EM, MacArthur BD, Lachmann A, Rozov R, Ma'ayan A, Boyer LA, Troyanskaya OG, Whetton AD, Lemischka IR. Systems-level dynamic analyses of fate change in murine embryonic stem cells. Nature 2009; 462: 358-362.
58. Schwanhäusser B, Busse D, Li N, Dittmar G, Schuchhardt J, Wolf J, Chen W, Selbach M. Global quantification of mammalian gene expression control. Nature 2011; 473: 337-342.
59. Rabani M, Levin JZ, Fan L, Adiconis X, Raychowdhury R, Garber M, Gnirke A, Nusbaum C, Hacohen N, Friedman N, Amit I, Regev A. Metabolic labeling of RNA uncovers principles of RNA production and degradation dynamics in mammalian cells. Nat Biotechnol 2011; 29: 436-442.
60. Gouraud SS, Heesom K, Yao ST, Qiu J, Paton JF, Murphy D. Dehydration-induced proteome changes in the rat hypothalamo-neurohypophyseal system. Endocrinology 2007; 148: 3041-3052.
61. Mzhavia N, Berman Y, Che FY, Fricker LD, Devi LA. ProSAAS processing in mouse brain and pituitary. J Biol Chem 2001; 276: 6207-6213.
62. Dong W, Seidel B, Marcinkiewicz M, Chretien M, Seidah NG, Day R. Cellular localization of the prohormone convertases in the hypothalamic paraventricular and supraoptic nuclei: selective regulation of PC1 in corticotrophin-releasing hormone parvocellular neurons mediated by glucocorticoids. J Neurosci 1997; 17: 563.
63. Pan H, Nanno D, Che FY, Zhu X, Salton SR, Steiner DF, Fricker LD, Devi LA. Neuropeptide processing profile in mice lacking prohormone convertase-1. Biochemistry 2005; 44: 4939-4948.
64. Fricker LD, McKinzie AA, Sun J, Curran E, Qian Y, Yan L, Patterson SD, Courchesne PL, Richards B, Levin N, Mzhavia N, Devi LA, Douglass J. Identification and characterization of proSAAS, a granin-like neuroendocrine peptide precursor that inhibits prohormone processing. J Neurosci 2000; 20: 639-648.
65. Qian Y, Devi LA, Mzhavia N, Munzer S, Seidah NG, Fricker LD. The C-terminal region of proSAAS is a potent inhibitor of prohormone convertase 1. J Biol Chem 2000; 275: 23596-23601.
66. Cameron A, Fortenberry Y, Lindberg I. The SAAS granin exhibits structural and functional homology to 7B2 and contains a highly potent hexapeptide inhibitor of PC1. FEBS Lett 2000; 473: 135-138.
67. Mzhavia N, Qian Y, Feng Y, Che FY, Devi LA, Fricker LD. Processing of proSAAS in neuroendocrine cell lines. Biochem J 2002; 361: 67-76.
68. Wei S, Feng Y, Che FY, Pan H, Mzhavia N, Devi LA, McKinzie AA, Levin N, Richards WG, Fricker LD. Obesity and diabetes in transgenic mice expressing proSAAS. J Endocrinol 2004; 180: 357-368.
69. Ghorbel MT, Sharman G, Leroux M, Barrett T, Donovan DM, Becker KG, Murphy D. Microarray analysis reveals interleukin-6 as a novel secretory product of the hypothalamo-neurohypophyseal system. J Biol Chem 2003; 278: 19280.
70. Strand FL. Neuropeptides: Regulators of Physiological Processes. Cambridge, MA: MIT Press, 1999.
71. Southey BR, Amare A, Zimmerman TA, Sweedler JV. NeuroPred: a tool to predict cleavage sites in neuropeptide precursors and provide the masses of the resulting peptides. Nucelic Acids Res 2006; 34: W267-W272.
72. Li L, Sweedler JV. Peptides in our brain: mass spectrometric-based measurement approaches and challenges. Annu Rev Anal Chem 2008; 1: 451-483.
73. Fricker LD, Lim J, Pan H, Che FY. Peptidomics: identification and quantification of endogenous peptides in neuroendocrine tissues. Mass Spectrom Rev 2006; 25: 327-344.
74. Lee JE, Atkins N, Hatcher NG, Zamdborg L, Gillette MU, Sweedler JV, Kelleher NL. Endogenous peptide discovery of the rat circadian clock: a focused study of the suprachiasmatic nucleus by ultrahigh performance tandem mass spectrometry. Mol Cell Proteomics 2010; 9: 285-297.
75. Bora A, Annangudi SP, Millet LJ, Rubakhin SS, Forbes AJ, Kelleher NL, Gillette MU, Sweedler JV. Neuropeptidomics of the supraoptic rat nucleus. J Proteome Res 2008; 7: 4992-5003.
76. Rubakhin SS, Greenough WT, Sweedler JV. Spatial profiling with MALDI MS: distribution of neuropeptides within single neurons. Anal Chem 2003; 75: 5374-5380.
77. Rubakhin SS, Churchill JD, Greenough WT, Sweedler JV. Profiling signaling peptides in single mammalian cells using mass spectrometry. Anal Chem 2006; 78: 7267-7272.
78. Millet LJ, Bora A, Sweedler JV, Gillette MU. Direct cellular peptidomics of supraoptic magnocellular and hippocampal neurons in low-density co-cultures. ACS Chem Neurosci 2010; 1: 36-48.
79. Hatcher NG, Atkins N, Annangudi SP, Forbes AJ, Kelleher NL, Gillette MU, Sweedler JV. Mass spectrometry-based discovery of circadian peptides. Proc Natl Acad Sci USA 2008; 105: 12527-12532.
80. Mitchell JW, Atkins N, Sweedler JV, Gillette MU. Direct cellular peptidomics of hypothalamic neurons. Front Neuroendocrinol 2011; 32: 377-386.
81. Atkins N, Mitchell JW, Romanova EV, Morgan DJ, Cominski TP, Ecker JL, Pintar JE, Sweedler JV, Gillette MU. Circadian integration of glutamatergic signals by little SAAS in novel suprachiasmatic circuits. PLoS ONE 2010; 5: e12612.
82. Young WS III, Gainer H. Transgenesis and the study of expression, cellular targeting and function of oxytocin, vasopressin and their receptors. Neuroendocrinology 2003; 78: 185-203.
83. Murphy D, Wells S. In vivo gene transfer studies on the regulation and function of the vasopressin and oxytocin genes. J Neuroendocrinol 2003; 15: 109-125.
84. Davies J, Waller S, Zeng Q, Wells S, Murphy D. Further delineation of the sequences required for the expression and physiological regulation of the vasopressin gene in transgenic rat hypothalamic magnocellular neurons. J Neuroendocrinol 2003; 15: 42-50.
85. Ueta Y, Fujihara H, Serino R, Dayanithi G, Ozawa H, Matsuda K, Kawata M, Yamada J, Ueno S, Fukuda A, Murphy D. Transgenic expression of enhanced green fluorescent protein enables direct visualization for physiological studies of vasopressin neurons and isolated nerve terminals of the rat. Endocrinology 2005; 146: 406-413.
86. Katoh A, Fujihara H, Ohbuchi T, Onaka T, Hashimoto T, Kawata M, Suzuki H, Ueta Y. Highly visible expression of an oxytocin-monomeric red fluorescent protein 1 fusion gene in the hypothalamus and posterior pituitary of transgenic rats. Endocrinology 2011; 152: 2768-2774.
87. de Vries GJ, Miller MA. Anatomy and function of extrahypothalamic vasopressin systems in the brain. Prog Brain Res 1998; 119: 3-20.
88. Maruyama T, Ohbuchi T, Fujihara H, Shibata M, Mori K, Murphy D, Dayanithi G, Ueta Y. Diurnal changes of arginine vasopressin-enhanced green fluorescent protein transfusion gene expression in the rat suprachiasmatic nucleus. Peptides 2010; 31: 2089-2093.
89. Todoroki M, Ueta Y, Fujihara H, Otsubo H, Shibata M, Hashimoto H, Kobayashi M, Sakamoto H, Kawata M, Dayanithi G, Murphy D, Hiro H, Takahashi K, Nagata S. Induction of the arginine vasopressin-enhanced green fluorescent protein fusion transgene in the rat locus coerules. Stress 2010; 13: 281-291.
90. Fujio T, Fujihara H, Shibata M, Yamada S, Onaka T, Tanaka K, Morita H, Dayanithi G, Kawata M, Murphy D, Ueta Y. Exaggerated response of arginine vasopressin-enhanced green fluorescent protein fusion gene to salt loading without disturbance of body fluid homeostasis in rats. J Neuroendocrinol 2006; 18: 776-785.
91. Shibata M, Fujihara H, Suzuki H, Ozawa H, Kawata M, Dayanithi G, Murphy D, Ueta Y. Physiological studies of stress responses in the hypothalamus of vasopressin-enhanced green fluorescent protein transgenic rat. J Neuroendocrinol 2007; 19: 285-292.
92. Suzuki H, Kawasaki M, Ohnishi H, Otsubo H, Ohbuchi T, Katoh A, Hashimoto H, Yokoyama T, Fujihara H, Dayanithi G, Murphy D, Nakamura T, Ueta Y. Exaggerated response of a vasopressin-enhanced green fluorescent protein transgene to nociceptive stimulation in the rat. J Neurosci 2009; 29: 13182-13189.
93. Ohbuchi T, Sato K, Suzuki H, Okada Y, Dayanithi G, Murphy D, Ueta Y. Acid-sensing ion channels in rat hypothalamic vasopressin neurons of the supraoptic nucleus. J Physiol 2010; 588: 2147-2162.
94. Ostrowski NL, Lolait SJ, Bradley DJ, O'Carroll AM, Brownstein MJ, Young WS III. Distribution of V1a and V2 vasopressin receptor messenger ribonucleic acid in rat liver, kidney, pituitary and brain. Endocrinology 1992; 131: 533-535.
95. Koshimizu TA, Nasa Y, Tanoue A, Oikawa R, Kawahara Y, Kiyono Y, Adachi T, Tanaka T, Kuwaki T, Mori T, Takeo S, Okamura H, Tsujimoto G. V1a vasopressin receptors maintain normal blood pressure by regulating circulating blood volume and baroreflex sensitivity. Proc Natl Acad Sci USA 2006; 16: 7807-7812.
96. Unger T, Rohmeiss P, Demmert G, Ganten D, Lang R, Luft F. Differential modulation of the baroreceptor reflex by brain and plasma vasopressin. Hypertension 1986; 8: II157-II162.
97. Ludwing M. Functional role of intrahypothalamic release of oxytocin and vasopressin: consequences and controversies. Am J Physiol 2005; 265: E537-E545.
98. Doherty FC, Schaack JB, Sladek CD. Comparison of the efficacy of four viral vectors for transducing hypothalamic magnocellularneurosecretory neurons in the rat supraoptic nucleus. J Neurosci Meth 2011; 197: 238-248.
99. Lončar-Turukalo T, Bajić D, Japundžić-Žigon N. Temporal sequence parameters in isodistributional surrogate data: model and exact expressions. IEEE Trans Biomed Eng 2011; 58: 16-24.
100. Bajić D, Loncar-Turukalo T, Stojicić S, Sarenac O, Bojić T, Murphy D, Paton JF, Japundzić-Zigon N. Temporal analysis of the spontaneous baroreceptor reflex during mild emotional stress in the rat. Stress 2010; 13: 142-154.
101. Oosting J, Struijker-Boudier HAJ, Janssen BJA. Validation of a continuous baroreceptor reflex sensitivity index calculated from spontaneous fluctuations of blood. J Hypertens 1997; 15: 391-399.
102. Stoijičić S, Milutinović-Smiljanić S, Šarenac O, Milosavljević S, Paton JFR, Murphy D, Japundžić-Žigon N. Blockade of central vasopressin reduces the cardiovascular response to acute stress in freely moving rats. Neuropharmacology 2008; 54: 824-836.
103. Milutinović S, Murphy D, Japundžić-Žigon N. The role of central vasopressin receptors in the modulation of autonomic cardiovascular controls: a spectral analysis study. Am J Physiol 2006; 291: R1579-R1591.
104. Narkiewicz K, Grassi G. Impaired baroreflex sensitivity as a potential marker of cardiovascular risk in hypertension. J Hypertens 2008; 26: 1303-1304.
105. Mortara A, La Rovere MT, Pinna GD, Prpa A, Maestri R, Febo O, Pozzoli M, Opasich C, Tavazzi L. Arterial baroreflex modulation of heart rate in chronic heart failure. Clinical and hemodynamic correlates and prognostic implications. Circulation 1997; 96: 3450-3458.
106. Osten P, Grinevich V, Cetin A. Viral vectors: a wide range of choices and high levels of service. Handb Exp Pharmacol 2007; 178: 177-202.
107. Knobloch S, Charlet A, Hoffmann LC, Eliava M, Khrulev S, Cetin AH, Osten P, Schwarz MK, Seeburg PH, Stoop R, Grinevich V. Evoked axonal oxytocin release in the central amygdala attenuates fear response. Neuron; In Press.